바로가기 메뉴
본문내용 바로가기
하단내용 바로가기

메뉴보기

메뉴보기

발표연제 검색

연제번호 : P 2-135 북마크
제목 ESWT to Treat Refractory Neurogenic Heterotopic Ossification in Patien with Spinal Cord Injury
소속 Veterans Health Service Medical Center, Seoul, Korea, Department of Physical Medicine and Rehabilitation1
저자 Hyun Min Jeon1*, Kyung Hee Do1†, Won-Jae Lee1, Hee Sup Chung1
Abstract
Neurogenic heterotopic ossification (NHO) is a common complication in central nervous system injuries including spinal cord injury (SCI), and significant pain can reduce the quality of life. Here, we reported the case of a 55-year-old male with C4 [S(C7/C7), M(C4/C4)] ASIA Impairment Scale A SCI due to cervical myelopathy, who experienced painful NHO around the right hip joint. His pain had been treated with medications (aceclofenac 100mg twice a day and disodium etidronate 600mg once a day) and physical modalities during a minimum of 3 weeks, however, he still exhibited severe pain with a Numeric Pain Rating Scale score of 7 to 8. In addition, because of his severe pain, he could not sit on the wheelchair at all. Ultrasound-guided extracorporeal shock wave therapy (ESWT) was administered to the area of NHO a total of 7 times, intensity of 6-7, weekly. After treatments, his pain reduced to VAS 3 and he also could sit on wheelchair more than 10 hours, although the size of NHO remained unchanged. In addition, these therapeutic effects of ESWT for NHO lasted for 6 months. To the best of our knowledge, this is the first case report for treatment of NHO using ESWT in patients with SCI. Therefore, the application of ESWT would constitute a possible alternative to other treatment techniques for treatment of NHO in patients with SCI.
File.1: Figure 1.gif
Figure 1 Sagittal T2 magnetic resonance image demonstrating spinal cord injury with focal high signal intensity spinal cord lesion
File.2: Figure 2.gif
Figure 2 Radiograph of the hip showed neurogenic heterotopic ossification before extracorporeal shock wave therapy treatment